Companies Dominating the Capillary and Venous Blood Sampling Devices Market
- B. Braun SE
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- BD
- Bio-Rad Laboratories, Inc.
- Greiner Bio-One International GmbH
- Lepu Medical Technology (Beijing) Co.,Ltd.
- Nova Biomedical
- Owen Mumford
- SARSTEDT AG & Co. KG
- Siemens Healthineers AG
- Terumo Corporation
- Thermo Fisher Scientific Inc.
The competitive strategies being adopted in the global capillary and venous blood sampling devices market include technological advancement, acquisitions, collaboration, and approval. Some of the key players in the market are B. Braun Melsungen AG, Shanghai Sunway Biotech Co., Ltd., Becton, Dickinson and Company (BD), Medtronic Plc, Merck KGaA, Bio-Rad Laboratories, Inc., Greiner Bio-One International GmbH, Ypsomed Holding AG, Owen Mumford Ltd, SB-KAWASUMI LABORATORIES, INC, Terumo Corporation, and Thermo Fisher Scientific. These companies continue to diversify their product offerings in order to increase effectiveness, reduce suffering, and increase adherence.
Due to the increasing concerns for contamination risks and better accuracy in sample collection, manufacturers are incorporating various filtration and micro sampling mechanisms to reduce the risk to patients. In January 2025, Terumo Corporation released its Injection Filter Needle, which is a part of the INFINO Development Program, and helps to minimize the risk of particle contamination in hypodermic and intravitreal injections. This advancement shows the industry’s keen interest in improving the sampling of blood, meeting healthcare standards and the general wellbeing of the patients.
Here are some leading companies in the capillary and venous blood sampling devices market:
